BLBCs are similar and are often used to indicate another group of neoplasms, namely triple-negative breast cancers (TNBCs), which are characterized by the lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (Her2/neu). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.